⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001582285

Wechsler Daniel Mark

Reports to the SEC for 2 companies · LAVAL, A8

Transactions

6

Companies

2

Filings

4

CIK

0001582285

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-06-12	MELINTA THERAPEUTICS, INC. /NEW/Stock Option (right to buy)A Award	Director, See Remarks	AAward	+150K sh	—	—	150,000
2018-05-29	MELINTA THERAPEUTICS, INC. /NEW/P Purchase	Director, See Remarks	PPurchase	+50K sh	$5.00	+$250K	50,000
2017-11-03	MELINTA THERAPEUTICS, INC. /NEW/Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+551K sh	—	—	550,981
2017-11-03	MELINTA THERAPEUTICS, INC. /NEW/Restricted Stock UnitsA Award	Director, See Remarks	AAward	+184K sh	—	—	183,661
2013-08-12	BHCBausch Health Companies Inc. · Restricted Share UnitsA Award	EVO, Co. Grp. Chmn, Eye Health	AAward	+31.6K sh	—	—	31,600
2013-08-12	BHCBausch Health Companies Inc. · Non-Qualified StockA Award	EVO, Co. Grp. Chmn, Eye Health	AAward	+82K sh	—	—	82,000

Recent filings

4

Accepted (ET)
Jun 144
Wechsler Daniel Mark0000899243-18-016624
SEC(opens sec.gov)
May 314
Wechsler Daniel Mark0000899243-18-014563
SEC(opens sec.gov)
Nov 74
Wechsler Daniel Mark0001209191-17-059614
SEC(opens sec.gov)
Aug 144
Valeant Pharmaceuticals International, Inc.0000885590-13-000072
SEC(opens sec.gov)

Companies

2

Address

2150 ST. ELZEAR BLVD. WEST

LAVAL, A8, H7L 4A8